International Trade Bulletin - Volume 1, Issue 4
Client Alert | 1 min read | 05.01.06
Inside this issue:
- CHINA IN THE SPOTLIGHT
- Intellectual Property: The U.S. and Japan recently announced a joint initiative to strengthen the protection and enforcement of intellectual property rights (IPR) in China and other third countries
- Market Access: The World Trade Organization completed its first Trade Policy Review report of China which concludes that, although China has achieved success in its trade and investment reforms, it still faces challenges
- EUROPE IN THE SPOTLIGHT
- Customs: The recent EU WTO "victory" over the U.S. on customs practices in Europe may seem like a blow to businesses facing customs clearance problems in the EU
- Counterfeit: The EU is to introduce harmonized criminal sanctions and heavy fines for infringements of intellectual property rights throughout the EU
- BILATERAL TRADE: Cross Lander's Investment in Romanian Auto Company Hits Rocky Terrain
- INVESTMENT: Representative Edward Markey, member of the House Homeland Security Committee, announces his intention to introduce an amendment to the Safe Ports Bill requiring inspection of all cargo coming into U.S. seaports
- TRADE REMEDIES: Is Zeroing Finally Dead?
- EXPORT CONTROLS: Recent Cancelled Sale of U.S. Computer Technology to China Highlights Concern over New Planned “Catch-All” Export Rule
- TRADE RETALIATION: The EU imposes punitive duties on eight additional U.S. products as retaliation against the U.S. Byrd law
Contacts
Insights
Client Alert | 5 min read | 04.23.26
CMS Proposes New Payment Policy for IOPOs and HCLs
In keeping with ongoing efforts to intensify regulatory oversight of organ procurement organizations (OPOs) and curtail improper spending within federal health programs, the Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule that would, among other adjustments, align Medicare payment policies for non-renal organs to be consistent with those currently applicable to kidneys. If enacted as drafted, this latest rule could have a direct impact on the financial stability of OPOs and histocompatibility laboratories (HCL) at a time when such organizations face increasing pressure to meet CMS’s new outcome measures — or else face non-renewal or decertification later this year.
Client Alert | 2 min read | 04.23.26
Two Lawsuits in One: The Growing Risk of Pairing Biometric Tech With Wage-and-Hour Violations
Client Alert | 3 min read | 04.22.26
Client Alert | 10 min read | 04.22.26
The EU Industrial Accelerator Act Proposal’s Significance for the Automotive Industry
